ViroPharma, Inc. (NASDAQ:VPHM)
| CAPS Rating |
|
|---|
VPHM
VS S&P 500 (SPY)
VPHM News and Commentary
- 4 Highly Liquid Biotech Stocks Being Snapped Up By Insiders – SeekingAlpha
- Investing 101: Biotech Stocks With Insider Buying – The Motley Fool
- Abbott Stands Up to Obamacare – The Motley Fool
- Are Supply Troubles a Biotech Buying Opportunity? – The Motley Fool
- ViroPharma Falters, Guides Lower - Analyst Blog – NASDAQ
- ViroPharma Misses on Both Revenue and Earnings – The Motley Fool
- Why ViroPharma Shares Got Pummeled – The Motley Fool
- The Big Bet on Protalix – The Motley Fool
- Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeut – NASDAQ
How do you think VPHM will perform against the market?
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
Powered by: CAPSAll Players
1,210
Outperform
39
Underperform
All-Star Players
289
Outperform
7
Underperform
Wall Street
19
Outperform
2
Underperform
RSS Headlines
Fool UK
